The assignee for this patent application is
Reporters obtained the following quote from the background information supplied by the inventors: "This invention relates to stents and methods of fabricating bioabsorbable stents with a prohealing layer.
"This invention relates to radially expandable endoprostheses, which are adapted to be implanted in a bodily lumen. An 'endoprosthesis' corresponds to an artificial device that is placed inside the body. A 'lumen' refers to a cavity of a tubular organ such as a blood vessel.
"A stent is an example of such an endoprosthesis. Stents are generally cylindrically shaped devices, which function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts. Stents are often used in the treatment of atherosclerotic stenosis in blood vessels. 'Stenosis' refers to a narrowing or constriction of the diameter of a bodily passage or orifice. In such treatments, stents reinforce body vessels and prevent restenosis following angioplasty in the vascular system. 'Restenosis' refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been treated (as by balloon angioplasty, stenting, or valvuloplasty) with apparent success.
"The treatment of a diseased site or lesion with a stent involves both delivery and deployment of the stent. 'Delivery' refers to introducing and transporting the stent through a bodily lumen to a region, such as a lesion, in a vessel that requires treatment. 'Deployment' corresponds to the expanding of the stent within the lumen at the treatment region. Delivery and deployment of a stent are accomplished by positioning the stent about one end of a catheter, inserting the end of the catheter through the skin into a bodily lumen, advancing the catheter in the bodily lumen to a desired treatment location, expanding the stent at the treatment location, and removing the catheter from the lumen. The stent may be visualized during delivery and deployment using X-Ray fluoroscopy if it contains radiopaque materials.
"In the case of a balloon expandable stent, the stent is mounted about a balloon disposed on the catheter. Mounting the stent typically involves compressing or crimping the stent onto the balloon. The stent is then expanded by inflating the balloon. The balloon may then be deflated and the catheter withdrawn. In the case of a self-expanding stent, the stent may be secured to the catheter via a constraining member such as a retractable sheath or a sock. When the stent is in a desired bodily location, the sheath may be withdrawn which allows the stent to self-expand.
"The stent must be able to satisfy a number of mechanical requirements. First, the stent must be capable of withstanding the structural loads, namely radial compressive forces, imposed on the stent as it supports the walls of a vessel. Therefore, a stent must possess adequate radial strength. Radial strength, which is the ability of a stent to resist radial compressive forces, is due to strength and rigidity around a circumferential direction of the stent. Radial strength and rigidity, therefore, may also be described as, hoop or circumferential strength and rigidity.
"Once expanded, the stent must adequately maintain its size and shape throughout its service life despite the various forces that may come to bear on it, including the cyclic loading induced by the beating heart. For example, a radially directed force may tend to cause a stent to recoil inward. Generally, it is desirable to minimize recoil. In addition, the stent must possess sufficient flexibility to allow for crimping, expansion, and cyclic loading. Longitudinal flexibility is important to allow the stent to be maneuvered through a tortuous vascular path and to enable it to conform to a deployment site that may not be linear or may be subject to flexure. Finally, the stent should be biocompatible so as not to trigger any adverse vascular responses.
"The structure of a stent is typically composed of scaffolding that includes a pattern or network of interconnecting structural elements often referred to in the art as struts or bar arms. The scaffolding can be formed from wires, tubes, or sheets of material rolled into a cylindrical shape. The scaffolding is designed so that the stent can be radially compressed (to allow crimping) and radially expanded (to allow deployment). A conventional stent is allowed to expand and contract through movement of individual structural elements of a pattern with respect to each other.
"Additionally, a medicated stent may be fabricated by coating the surface of either a metallic or polymeric scaffolding with a polymeric carrier that includes an active or bioactive agent or drug. Polymeric scaffolding may also serve as a carrier of an active agent or drug.
"Furthermore, it may be desirable for a stent to be biodegradable. In many treatment applications, the presence of a stent in a body may be necessary for a limited period of time until its intended function of, for example, maintaining vascular patency and/or drug delivery is accomplished. Therefore, stents fabricated from biodegradable, bioabsorbable, and/or bioerodable materials such as bioabsorbable polymers should be configured to completely erode only after the clinical need for them has ended."
In addition to obtaining background information on this patent application, NewsRx editors also obtained the inventors' summary information for this patent application: "Various embodiments of the present invention include a stent comprising: a bioabsorbable prohealing layer configured to promote endothelialization upon exposure to bodily fluids; and a bioabsorbable drug-polymer layer above a luminal surface of the prohealing layer.
"Further embodiments of the present invention include a method of fabricating a bioabsorbable stent, the method comprising: forming a bioabsorbable prohealing coating layer over a bioabsorbable base polymer tube, the prohealing coating layer configured to promote endothelialization upon exposure to bodily fluids; forming a bioabsorbable drug-polymer layer over the prohealing coating layer; and laser cutting a stent pattern in the coated polymer tube to form a stent.
BRIEF DESCRIPTION OF THE DRAWINGS
"FIG. 1 depicts a view of a stent.
"FIG. 2 depicts an exemplary embodiment a strut with an endothelial cell progenitor layer.
"FIG. 3 depicts an exemplary embodiment a strut with an endothelial cell progenitor layer and a drug-polymer layer.
"FIG. 4 depicts an exemplary embodiment a strut with an endothelial cell progenitor layer and two drug-polymer layers.
"FIG. 5 depicts an alternative to FIG. 4 with a drug-polymer coating layer around the luminal, abluminal, and sidewall surfaces of a strut.
"FIG. 6 depicts a process flowchart illustrating the fabrication of an exemplary stent as depicted in FIG. 4 or 5"
For more information, see this patent application: Fox,
Keywords for this news article include: Treatment, Endothelial Cells,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Microsoft Releases Free OneNote for Mac
- E.U. Puts Sanctions on Russia, Ukraine Officials
- Crimea Seeks Financial Integration With Russia
- Homebuilders Show Rising Confidence in Market
- Jack Daniel's Resists Changes to Tenn. Whiskey Law
- Apple, HP, Intel May Take a Hit from Slowdown in Smartphone Sales Growth
- Obama Imposes Sanctions on Russian Officials
- Chile Shaken by Major Aftershock
- Ford Flies High on Speed
- 'Walking Dead' Takes a Shocking Turn: Recap